je.st
news
Tag: biotech
Activist Investor Paul Singer Ups His Stake In The Re-Branded Fortress Biotech Inc.
2015-07-21 00:51:54| Biotech - Topix.net
According to a recent Schedule 13G form filed with the Securities and Exchange Commission, Paul Singer 's Elliott Associates L.P. owns 2.43 million shares in Fortress Biotech Inc. , which represent 5.18% of the company's outstanding common stock. This marks an increase of the fund's equity holding in Fortress Biotech of 1.98 million shares since its most recent 13F filing with the SEC for the reporting period of March 31. Elliott Management Corporation currently manages hedge funds Elliott Associates L.P. and Elliott International Limited, which together have more than $25 billion in assets under management as of December 31, 2014.
Healthcare Providers Push Past Biotech Stocks In Krishen Sud's Portfolio
2015-07-20 17:36:32| Biotech - Topix.net
Krishen Sud 's Sivik Global Healthcare LLC has filed its 13F with the SEC for the end of second quarter reporting period and the filing reveals that healthcare providers have made their way past biotech stocks in his portfolio. The healthcare-focused investment manager reported a public equity portfolio valued at $288.19 million as of June 30. Krishen Sud is known for investing heavily in healthcare, and 91% of his overall portfolio was dedicated to healthcare stock picks as of the reporting period.
Tags: past
providers
portfolio
push
Putting Eli Lilly's Biotech Bounce to the Test
2015-07-20 03:01:22| Biotech - Topix.net
Eli Lilly is the big pharmaceutical company that, due to its Alzheimer's program, suddenly trades like a biotechnology stock. Investors should be poised to sell.
Tags: test
putting
eli
biotech
How Genzyme became a big source of biotech executives
2015-07-19 04:11:51| Biotech - Topix.net
Retired Genzyme CEO Henri Termeer stands outside his office in Marblehead. He is one of the "Genzyme diaspora," an elite group of colleagues who once lead the most cutting-edge biotech firm in the age when biotechnology was still in its formative years.
Tags: of
big
source
executives
Premarket Biotech Digest: Options Trading, Achillion Short Interest, Opdivo EU Approval
2015-07-18 14:38:03| Biotech - Topix.net
I am no options expert, but I have written covered calls occasionally to boost returns on some of my holdings. Writing covered calls can be a useful strategy with large cap biopharmas like Pfizer , Merck , Johnson & Johnson and Eli Lilly .
Tags: options
short
interest
trading
Sites : [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] next »